314 related articles for article (PubMed ID: 34472711)
1. Comprehensive analysis of pan-cancer reveals potential of ASF1B as a prognostic and immunological biomarker.
Hu X; Zhu H; Zhang X; He X; Xu X
Cancer Med; 2021 Oct; 10(19):6897-6916. PubMed ID: 34472711
[TBL] [Abstract][Full Text] [Related]
2. Protumor Effects of Histone H3-H4 Chaperone Antisilencing Feature 1B Gene on Lung Adenocarcinoma: In Silico and
Wu L; Jie B
Comput Math Methods Med; 2021; 2021():5005459. PubMed ID: 34956399
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment.
Ma J; Han W; Lu K
Front Oncol; 2021; 11():711756. PubMed ID: 34490109
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
Liu P; Wang X; Pan L; Han B; He Z
Front Immunol; 2022; 13():901784. PubMed ID: 35720327
[TBL] [Abstract][Full Text] [Related]
5. Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.
Huang D; Shen J; Zhai L; Chen H; Fei J; Zhu X; Zhou J
Front Immunol; 2021; 12():812713. PubMed ID: 35069601
[TBL] [Abstract][Full Text] [Related]
6. Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role.
Zhu H; Hu X; Ye Y; Jian Z; Zhong Y; Gu L; Xiong X
Front Genet; 2021; 12():687778. PubMed ID: 34594356
[TBL] [Abstract][Full Text] [Related]
7. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
8. Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker.
Xu L; Wu P; Rong A; Li K; Xiao X; Zhang Y; Wu H
Aging (Albany NY); 2023 May; 15(10):4269-4287. PubMed ID: 37199628
[TBL] [Abstract][Full Text] [Related]
9. ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma.
Zhang S; Xu L; Feng J; Tan D; Zhu Y; Hou J; Li W; Lv K; Wang W; Jiang L; Jiao M; Guo H
Front Genet; 2022; 13():842351. PubMed ID: 35360875
[No Abstract] [Full Text] [Related]
10.
Li R; Cui X; Sun W; Yang Z; Shen X; Zhu C
Comb Chem High Throughput Screen; 2023; 26(7):1311-1323. PubMed ID: 35993469
[TBL] [Abstract][Full Text] [Related]
11. ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types.
Zhang W; Gao Z; Guan M; Liu N; Meng F; Wang G
Front Oncol; 2021; 11():731547. PubMed ID: 34568067
[TBL] [Abstract][Full Text] [Related]
12. Carcinogenic Role and Clinical Significance of Histone H3-H4 Chaperone Anti-silencing Function 1 B (ASF1B) in Lung Adenocarcinoma.
Song C; Song Y; Wan X; Zhao Z; Geng Q
J Cancer; 2024; 15(1):218-231. PubMed ID: 38164276
[TBL] [Abstract][Full Text] [Related]
13. ASF1B acted as a prognostic biomarker for stomach adenocarcinoma.
Zhao C; Zhou J; Xing J; Yin Q
Medicine (Baltimore); 2023 Dec; 102(48):e35408. PubMed ID: 38050219
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.
Liu XS; Chen YL; Chen YX; Wu RM; Tan F; Wang YL; Liu ZY; Gao Y; Pei ZJ
Sci Rep; 2024 Apr; 14(1):9881. PubMed ID: 38688977
[TBL] [Abstract][Full Text] [Related]
15. Histone chaperone ASF1B promotes human β-cell proliferation via recruitment of histone H3.3.
Paul PK; Rabaglia ME; Wang CY; Stapleton DS; Leng N; Kendziorski C; Lewis PW; Keller MP; Attie AD
Cell Cycle; 2016 Dec; 15(23):3191-3202. PubMed ID: 27753532
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
[TBL] [Abstract][Full Text] [Related]
17. The Hypoxia-Related Gene COL5A1 Is a Prognostic and Immunological Biomarker for Multiple Human Tumors.
Zhu H; Hu X; Feng S; Jian Z; Xu X; Gu L; Xiong X
Oxid Med Cell Longev; 2022; 2022():6419695. PubMed ID: 35082969
[TBL] [Abstract][Full Text] [Related]
18. Identification of ASF1B as a prognostic marker for liver cancer by meta-analysis and its immune value revealed by a comprehensive pan-cancer analysis of 33 human cancers.
Chen Y; Zhou W; Gong Y; Ou X
Prz Gastroenterol; 2023; 18(3):249-265. PubMed ID: 37937108
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis.
Li S; Li L; Pan T; Li X; Tong Y; Jin Y
Front Immunol; 2022; 13():977016. PubMed ID: 36211383
[TBL] [Abstract][Full Text] [Related]
20. Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker.
Zhang R; Wang W; Zhang N; Chen X; Liu W; Zhang L; Liu N
J Cell Mol Med; 2022 Sep; 26(18):4859-4871. PubMed ID: 35989423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]